Nucleotides regulate NaCl transport in mIMCD-K2 cells via P2X and P2Y purinergic receptors

David E. McCoy1, Amanda L. Taylor1, Brian A. Kudlow2, Katherine Karlson1, Margaret J. Slattery1, Lisa M. Schwiebert2, Erik M. Schwiebert2, and Bruce A. Stanton1

1 Department of Physiology, Dartmouth Medical School, Hanover, New Hampshire 03755; and 2 Department of Physiology and Biophysics, University of Alabama at Birmingham, Birmingham, Alabama 35294


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Extracellular nucleotides regulate NaCl transport in some epithelia. However, the effects of nucleotide agonists on NaCl transport in the renal inner medullary collecting duct (IMCD) are not known. The objective of this study was to determine whether ATP and related nucleotides regulate NaCl transport across mouse IMCD cell line (mIMCD-K2) epithelial monolayers and, if so, via what purinergic receptor subtypes. ATP and UTP inhibited Na+ absorption [measured via Na+ short-circuit current (INasc)] and stimulated Cl- secretion [measured via Cl- short-circuit current (IClsc)]. Using selective P2 agonists, we report that P2X and P2Y purinoceptors regulate INasc and IClsc. By RT-PCR, two P2X receptor channels (P2X3, P2X4) and two P2Y G protein-coupled receptors (P2Y1, P2Y2) were identified. Functional localization of P2 purinoceptors suggest that IClsc is stimulated by apical membrane-resident P2Y purinoceptors and P2X receptor channels, whereas INasc is inhibited by apical membrane-resident P2Y purinoceptors and P2X receptor channels. Together, we conclude that nucleotide agonists inhibit INasc across mIMCD-K2 monolayers through interactions with P2X and P2Y purinoceptors expressed on the apical plasma membrane, whereas extracellular nucleotides stimulate IClsc through interactions with P2X and P2Y purinoceptors expressed on the apical plasma membrane.

inner medullary collecting duct; short-circuit current; kidney


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

NUCLEOTIDES IN THE extracellular fluid act as autocrine and paracrine hormones to regulate a variety of physiological processes (1, 4, 9, 13, 21, 22). For example, nucleotides inhibit Na+ absorption and stimulate Cl- secretion across epithelia derived from many tissues (25, 30, 31, 36, 42, 44). In addition, nucleotides activate K+ channels in Madin-Darby canine kidney (MDCK) cells (19) and inhibit Na+ absorption across the rabbit cortical collecting duct (CCD) (32). Despite evidence documenting the effects of nucleotides on MDCK cells, A6 cells, and CCD cells (19, 32, 36, 44), the effects of nucleotides on NaCl transport in the inner medullary collecting duct (IMCD), the final nephron segment responsible for fine adjustments in NaCl excretion, are not known.

Once released from cells, nucleotides interact with specific plasma membrane-resident purinoceptors that act as ion channels or couple with phospholipases and adenylyl cyclase-driven signal transduction pathways (1, 4, 6, 9, 13, 14, 18, 22). Purinoceptors are divided into two classes: P1 (activated by adenosine) and P2 (activated by ATP and ADP) (1, 4, 6, 9, 13, 14, 18, 22). P2 purinoceptors have been subdivided into two families: P2X and P2Y (1, 4, 6, 9, 13, 14, 18, 22). The P2X purinoceptor family contains at least seven distinct subtypes (P2X1 through P2X7), each of which is a two transmembrane-spanning, ion channel-forming protein (5, 9, 11, 33, 34, 43, 45, 47). P2X receptor channels bind ATP and form Ca2+-permeable, nonselective cation channels that, when activated, increase intracellular Ca2+ by allowing Ca2+ entry from the extracellular fluid. P2Y purinoceptors are seven transmembrane-spanning, G protein-coupled metabotropic receptors containing at least six distinct receptor subtypes (P2Y1 through P2Y6) (1, 4, 6, 7, 12). P2Y purinoceptors are coupled to effectors through heterotrimeric G proteins and either stimulate (40) or inhibit (1, 13, 22) adenylyl cyclase. P2Y receptors also stimulate phospholipase activity and, in turn, increase intracellular Ca2+ (1, 4, 13, 22). In addition, P2Y purinoceptors enhance cAMP production through receptor-mediated prostaglandin release (39, 40).

Previously, we demonstrated that a cell line derived from mouse IMCD (mIMCD-K2) absorbs Na+ and secretes Cl- by electrogenic mechanisms (28, 29, 37, 48). Moreover, we demonstrated that the purine nucleoside, adenosine, through an interaction with adenosine A1 receptors, inhibits arginine vasopressin-stimulated Cl- secretion (37). Because ATP is released from IMCD cells (35) and is present in the urine (10) and because the effects of nucleotides on NaCl transport in the IMCD are not known, we tested the hypothesis that ATP and related nucleotides regulate NaCl transport across mIMCD-K2 cells. To this end, we examined the effect of selective P2Y or P2X agonists on electrogenic Cl- and Na+ transport across monolayers of mIMCD-K2 cells mounted in an Ussing chamber. Our results suggest that Cl- short-circuit current (IClsc) is stimulated by apical membrane-resident P2Y purinoceptors and P2X receptor channels, whereas Na+ short-circuit current (INasc) is inhibited by apical membrane-resident P2Y purinoceptors and P2X receptor channels. By RT-PCR, we also report that mIMCD-K2 cells express mRNA for P2X3 and P2X4 receptors and for P2Y1 and P2Y2 receptors that may transduce extracellular nucleotide signals. We conclude that nucleotide agonists stimulate IClsc while extracellular nucleotides inhibit INasc across mIMCD-K2 monolayers through interactions with P2X and P2Y purinoceptors expressed on the apical plasma membrane.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Cell culture. The mIMCD-K2 cell line was established by clonal dilution of IMCD cells isolated from transgenic mice [Tg(SV40E)Bri/7] and grown in continuous culture as described previously (28). Briefly, cells were cultured in tissue culture flasks (Costar, Cambridge, MA) coated with Vitrogen plating media (VPM) containing DMEM (JRH Biosciences, Lenexa, KS), human fibronectin (10 µg/ml; Collaborative Research Products, Bedford, MA), 1% Vitrogen 100 (Collagen, Palo Alto, CA), and BSA (10 µg/ml; Sigma Chemical, St. Louis, MO) and placed in an incubator maintained at 37°C and gassed with 5% CO2-95% air. Every 48 h, 100% of the medium, PC-1 (BioWhittaker, Walkersville, MD) supplemented with PC-1 medium supplement (BioWhittaker), 5% fetal bovine serum (FBS; Hyclone, Logan, UT), 2 mM L-glutamine (Life Technologies, Grand Island, NY), and 50 U/ml penicillin and 50 µg/ml streptomycin (Life Technologies), was replaced. At confluence, cells were subcultured by light trypsinization and reseeded in VPM-coated cell culture flasks. In some studies, mIMCD-K2 cells were grown in DMEM-Ham's F-12 medium (Life Technologies) supplemented with 10% FBS (Hyclone), 10 µg/ml insulin (Sigma), 5.5 µg/ml transferrin (Sigma), 5.0 pg/ml sodium selenite (Sigma), 5 µM dexamethasone, 2 mM L-glutamine, 50 U/ml penicillin, and 50 µg/ml streptomycin, rather than PC-1 medium. Experimental results were qualitatively and quantitatively similar regardless of the cell culture medium used. As demonstrated previously, mIMCD-K2 cells display many of the phenotypic properties of the IMCD, including electrogenic Na+ absorption and Cl- secretion (28, 29, 37, 48).

Measurement of short-circuit current in Ussing chambers. To measure electrogenic Na+ and Cl- currents, mIMCD-K2 cells were seeded at a density of 1.2 × 105 cells/0.6 cm2 on permeable, VPM-coated Cellagen filter supports (ICN Biomedicals, Aurora, OH) as described previously (28). Every 24 h, 100% of the medium was replaced. Cells between passages 11 and 20 were used for all experiments.

Short-circuit current (Isc) was measured by placing monolayers of mIMCD-K2 cells grown on Cellagen filters into an Ussing-type chamber (Jim's Instrument, Iowa City, IA) and voltage clamping the transepithelial voltage across the monolayer to 0 mV with a VCC-600 four-electrode voltage clamp (Physiological Instruments, Poway, CA) as described previously (28). Positive current represents the net flow of cations from the apical to the basolateral bath solution or the net flow of anions from the basolateral bath solution to the apical bath solution. Bath solutions were maintained at 37°C and were stirred by bubbling with 5% CO2-balance air. Electrical connections from the bath solutions to the voltage-clamp headstage were made with 5.0 M NaCl-4% agar bridges and Ag-AgCl wires. Current output from the clamp was digitized by a TL-1 DMA interface analog-to-digital converter (Axon Instruments, Foster City, CA). Data collection and analysis were done using Axotape 2.0 software (Axon Instruments).

To measure secretory Cl- current, PC-1 medium containing 140 mM NaCl was used on both sides of the monolayer. In these measurements, amiloride was added to block absorptive Na+ current (INasc) to measure IClsc specifically. To measure INasc, experiments were performed in Cl--free, sodium gluconate bath solutions composed of (in mM) 116 sodium gluconate, 3 potassium gluconate, 24 NaHCO3, 2 MgSO4, 8 HEPES, 8 glucose, and 2 CaSO4, adjusted to pH 7.4. Under these conditions, Isc is equivalent to INasc (28, 29, 37, 48).

Isc data analysis. Steady-state and peak values of the Isc were determined using Axotape software (Axon Instruments). Steady-state Isc was recorded as the average of the current data over 1 min when individual current values over that period differed by <1% of the mean current. Peak values were reported as the highest single Isc value measured after stimulation with agonist. Data are expressed as means ± SE. Differences between means in unpaired experiments were compared by repeated-measures ANOVA followed by Bonferroni's multiple comparisons test. Differences between means in paired experiments were compared by Student's t-test. All statistical analyses were performed with InStat statistical software (Graphpad, San Diego, CA). Statistical significance was ascribed for P < 0.05 or lower.

Preparation of total RNA for PCR. mIMCD-K2 cells were grown to confluence in collagen-coated flasks, and RNA was extracted using TRIzol reagent (Life Technologies), according to the manufacturer's instructions.

Preparation of cDNA. Total RNA was recovered by centrifugation, resuspended in diethyl pyrocarbonate (DEPC)-treated water (10-30 µl depending on size of pellet), and treated with RNase-free DNase (Life Technologies) to remove contaminating genomic DNA. Total RNA (2-4 µl) was mixed with 12-14 µl DEPC-H2O, 2 µl DNase buffer, and 2 µl RNase-free DNase I and incubated at room temperature for 15 min. Two microliters of 25 mM EDTA were added to chelate Ca2+ and Mg2+ to stop the reaction, and the DNase-treated samples were heated at 65°C for 10 min to inactivate DNase I activity. Moloney murine leukemia virus (MMLV)-RT (Life Technologies) was used to reverse transcribe total RNA to cDNA. Each reaction contained 20-22 µl of total RNA template (DNase-treated sample from above), 2.5 µl dNTP mix (mixture of dATP, dCTP, dGTP, and dTTP; Pharmacia, 2 µM each), 2 µl oligo(dT)12-18 primer (Life Technologies), 10 µl of 5× RT buffer, 2.5 µl dithiothreitol (0.1 M), 9.8 µl DEPC-H2O, and 2 µl MMLV-RT enzyme (Life Technologies). Oligo(dT) primer ensures that all messenger RNA species were reverse transcribed to cDNA. The reaction was incubated for 1 h at 37°C in a thermocycler. Complementary DNA (cDNA) samples were then incubated at 90°C for 5 min in the thermocycler to inactivate the RT enzyme.

PCR of epithelial cDNA. We used degenerate and specific PCR primers designed to amplify the P2X gene family and specific members of the P2Y receptor gene family, P2Y1 and P2Y2. P2X degenerate primers were designed to an alignment of rat P2X1, P2X2, and P2X3 (16). P2Y1 and P2Y2 primers were designed to the human cDNAs. Each PCR reaction contained 3-5 µl cDNA template, 33.8-35.8 µl ultraviolet-sterilized, double-distilled H2O, 1 µl dNTP mix (Pharmacia, 2 µM), 1 µl forward primer (A) and reverse primer (B) (2 µM final concentration; see primers below), 0.2 µl Taq polymerase (Perkin-Elmer), 5 µl of 10× PCR buffer, and 3 µl of MgCl2 solution (1.5 mM final concentration). The cycling parameters were established in 3 steps: 1) a 5-min, 94°C "hot start"; 2) 40 cycles of 30 s at 94°C, 1 min at appropriate "annealing" temperature (indicated with each primer pair below), and 1 min at 72°C; and 3) a 10-min "elongation" at 72°C to end the reaction. PCR products were visualized on a 1.5% agarose gel run with a 100-bp DNA ladder. PCR primers are shown below
&bgr;-actin <IT>A</IT>: 5′-TGA CGG GGT CAC CCA CAC TGT GCC 
CAT CTA-3′
&bgr;-actin <IT>B</IT>: 5′-CTA GAA GCA TTG CGG TGG ACG ATG 
GAG GG-3′
(60°C annealing temperature)
P2XR degenerate <IT>A</IT>: 5′-TTC ACC MTY YTC ATC AAR 
AAC AGC ATC-3′
P2XR degenerate <IT>B</IT>: 5′-TGG CAA AYC TGA AGT TGW 
AGC C-3′
(52°C annealing temperature)
P2Y1 <IT>A</IT>: 5′-AAG ACG GGC TTC CAG TTC TAC TAC-3′
P2Y1 <IT>B</IT>: 5′-CAC ATT TCT GGG GTC TGG AAA TCC-3′
(60°C annealing temperature)
P2Y2 <IT>A</IT>: 5′-CGT CAT CCT TGT CTG TTA CGT GCT-3′
P2Y2 <IT>B</IT>: 5′- CTA CAG CCG AAT GTC CTT AGT G-3′
(60°C annealing temperature)
beta -Actin PCR amplification was performed to authenticate that cDNA synthesis was successful in each sample using a housekeeping gene. Once beta -actin cDNA was detected and amplified, amplification with P2X or P2Y primer pairs could proceed on the authenticated cDNA samples.

DNA sequencing of PCR products. PCR products were isolated from agarose gel slices using the Qiaquick gel extraction kit (Qiagen). PCR products were ligated into the pGEM-T vector system (Promega) and were then transformed into JM109 high-efficiency competent cells (Promega). The grow-ups of the transformations were then plated on LB agar plates containing ampicillin (100 µg/ml), 5-bromo-4-chloro-3-indolyl-D-galactopyranoside (X-Gal; 40 µg/ml), and isopropyl-beta -thiogalactopyranoside (IPTG; 100 µg/ml) for ampicillin selection of successful transformants and for blue/white selection of successful PCR product ligation. White colonies were picked off the plate to inoculate a 6-ml LB grow-up with continued ampicillin selection. The pGEM-T plasmid with insert was purified from the grow-up using a PerfectPrep miniprep kit (5 Primeright-arrow3 Prime, Boulder, CO). The purified DNA was denatured in 0.2 N NaOH, precipitated in 7.5 M NH4Cl and 100% ethanol, and sequenced using the Sequenase dideoxy termination method (Amersham/US Biochemicals) using [alpha -35S]dATP (DuPont NEN) incorporation by our laboratories. The resulting DNA sequence was read by two independent investigators and screened with the basic local alignment research tool (BLAST) algorithm (2).


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Nucleotides regulate INasc and IClsc. To determine whether extracellular nucleotides regulate electrogenic Na+ and/or Cl- transport, we measured INasc and IClsc across monolayers of mIMCD-K2 cells mounted in Ussing chambers. ATP and UTP (100 µM) induced a small, insignificant increase of INasc followed by prolonged inhibition of INasc (Figs. 1 and 2). ATP and UTP transiently, but significantly, increased IClsc (Figs. 3 and 4). After the transient increase, IClsc returned gradually (~10 min) to levels not significantly different from Isc before the addition of ATP and UTP (Figs. 3 and 4). It is important to note that physiologically relevant concentrations of ATP (1 µM) also reduced INasc (-4.8 ± 1.5 µA/cm2; P < 0.05) and stimulated IClsc (4.2 ± 0.1 µA/cm2; P < 0.05).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 1.   ATP inhibits Na+ short-circuit current (INasc). Representative current record illustrating the effects of ATP on INasc is shown. ATP (100 µM) was added to the apical and basolateral bath solutions. Amiloride (10 µM) was added to the apical bath solution to inhibit Na+ absorption. Effects of UTP on Isc were qualitatively similar (representative record not shown). Decline in Isc at time 0 to steady-state (~10-12 min) has been described previously (28, 29, 37, 48).



View larger version (33K):
[in this window]
[in a new window]
 
Fig. 2.   ATP and UTP inhibit INasc. Data summary of the effects of ATP and UTP on INasc is given. ATP (100 µM) and UTP (100 µM) induced a small, transient increase in INasc (not significantly different from basal; P < 0.05), followed by a prolonged steady-state inhibition of INasc. After administration of amiloride, Isc was not significantly different from 0 µA/cm2, thereby indicating that Isc is referable to Na+ absorption. * P < 0.05 vs. basal.



View larger version (14K):
[in this window]
[in a new window]
 
Fig. 3.   ATP stimulates Cl- short-circuit current (IClsc). Representative current record illustrating the effects of ATP on IClsc is shown. ATP (100 µM) was added to the apical and basolateral bath solutions. Amiloride (10 µM) and diphenylamine-2-carboxylic acid (DPC; 10 mM), an inhibitor of Cl- channels, were added to the apical bath solution. Effects of UTP on Isc were qualitatively similar (representative record not shown).



View larger version (20K):
[in this window]
[in a new window]
 
Fig. 4.   ATP and UTP stimulate IClsc. Data summary of the effects of ATP and UTP on IClsc is given. ATP (100 µM) and UTP (100 µM) induced a transient, significant increase in IClsc, followed by a slow decline to a steady-state value significantly less than the peak value following administration of ATP or UTP. In the presence of amiloride and following administration of DPC, Isc was not significantly different from 0 µA/cm2, thereby indicating that Isc in amiloride-treated monolayers is referable to Cl- secretion. * P < 0.05 vs. amiloride-inhibited Isc.

Pharmacological identification of purinoceptors. To determine if P2X and/or P2Y receptors regulate INasc and IClsc, we used a pharmacological approach. ATP binds to both P2X and P2Y receptors (>= 1 µM); thus ATP cannot be used to discriminate between P2X and P2Y receptors. In contrast, UTP (1-100 µM) binds selectively to P2Y receptors and, in particular, to the P2U or P2Y2 receptors, whereas alpha ,beta -methylene-ATP (alpha ,beta -MeATP; 1-100 µM) and beta ,gamma -methylene-ATP (beta ,gamma -MeATP; 1-100 µM) bind selectively to P2X receptors (1, 11, 21). Therefore, UTP can be used to identify P2Y receptors and alpha ,beta -MeATP and beta ,gamma -MeATP can be used to identify P2X receptors. UTP (10 µM) reduced INasc by 4.8 ± 1.0 µA/cm2 (P < 0.05). alpha ,beta -MeATP (100 µM) and beta ,gamma -MeATP (100 µM) also reduced INasc by 2.0 ± 0.8 µA/cm2 (P < 0.05) and by 3.9 ± 0.9 µA/cm2 (P < 0.05), respectively. These results indicate that nucleotide inhibition of INasc across mIMCD-K2 cells is mediated by P2X and P2Y purinoceptors.

To determine whether P2X and/or P2Y purinoceptors regulate IClsc, we examined the effects of UTP, alpha ,beta -MeATP, and beta ,gamma -MeATP on IClsc. UTP (1 µM) transiently stimulated IClsc by 6.4 ± 0.4 µA/cm2 (P < 0.05). alpha ,beta -MeATP and beta ,gamma -MeATP (50 µM) transiently increased IClsc by 0.5 ± 0.1 µA/cm2 (P < 0.05) and 2.4 ± 0.2 µA/cm2 (P < 0.05), respectively. These results suggest that nucleotide stimulation of IClsc is mediated by P2Y and P2X purinoceptors.

Functional localization of P2Y and P2X purinoceptors. Experiments were conducted to determine if P2Y and P2X purinoceptors are expressed in the apical and/or basolateral plasma membranes of mIMCD-K2 cells. Because antibodies that recognize these receptors are not yet available, we used a pharmacological approach to determine if P2Y and P2X purinoceptors are expressed in the apical and/or basolateral membranes. UTP (100 µM) reduced INasc when added to the apical solution (Fig. 5). UTP also stimulated IClsc when added to the apical solution (Fig. 6). P2U purinoceptor-mediated effects in the basolateral membrane were not statistically significant. Therefore, P2Y purinoceptors are expressed predominantly in the apical plasma membrane.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 5.   Polarity of nucleotide receptor agonist effects on INasc. Sidedness of the effects of UTP, alpha ,beta -methylene-ATP (MeATP), and beta ,gamma -MeATP on INasc is shown. All 3 agonists had a significant effect when added to the apical solution. * P < 0.05 vs. amiloride-inhibited current.



View larger version (19K):
[in this window]
[in a new window]
 
Fig. 6.   Polarity of nucleotide receptor agonist effects on IClsc. Sidedness of the effects of UTP, alpha ,beta -MeATP, and beta ,gamma -MeATP on IClsc is shown. Although all 3 agonists increased IClsc significantly when added to the apical solution, they had no significant effect when added to the basolateral solution. * P < 0.05 vs. 0 µA/cm2.

alpha ,beta -MeATP and beta ,gamma -MeATP (100 µM) inhibited INasc and stimulated IClsc when added to the apical solution (Fig. 6). P2X purinoceptor-mediated effects in the basolateral membrane were not statistically significant. Thus P2X purinoceptors in the apical membrane inhibit INasc and stimulate IClsc.

Molecular identification of P2X and P2Y purinoceptors. Little is known about P2X and P2Y receptor expression in IMCD cells. Accordingly, to begin to identify which P2X and P2Y receptors are expressed in mIMCD-K2 cells, we identified P2X and P2Y receptor subtype mRNA expression by RT-PCR. RT-PCR for the housekeeping gene, beta -actin (750-bp product), was performed initially to authenticate a successful cDNA synthesis (Fig. 7A). The "no cDNA" and "no RT" negative PCR controls had no PCR product for all genes amplified (Fig. 7). PCR products of the expected size (330 bp) for P2X receptors were identified in mIMCD-K2 cells (Fig. 7B). A positive control was run in parallel that included a human pancreatic epithelial cell line (CFPAC-1). To confirm that the PCR products were indeed derived from P2X receptor mRNA and to determine which P2X receptor mRNAs are expressed in mIMCD-K2 cells, PCR products were sequenced. Of 32 minipreps processed from two different degenerate mIMCD-K2 P2X receptor PCR reactions, 14 sequences were identified through BLAST analysis as P2X3 and 18 were identified as P2X4 (Table 1). Representative sequence alignments for our mouse P2X3 and P2X4 PCR product with cloned rat cDNA sequences are shown in Fig. 8, A and B. These results suggest that P2X3 and P2X4 receptors may regulate transepithelial NaCl transport by mIMCD-K2 monolayers.


View larger version (55K):
[in this window]
[in a new window]
 
Fig. 7.   P2X and P2Y receptors are expressed by a mouse inner medullary collecting duct cell line (mIMCD-K2 cells). A: amplification of beta -actin (750-bp PCR product) to verify a successful cDNA synthesis (CFPAC-1 cells used as a positive control for P2X receptors). Amplification of P2 purinoceptors was conducted using degenerate primers for the P2X receptor gene family (330-bp PCR product) in B, using specific primers for the P2Y1 gene (750-bp PCR product) in C, and using specific primers for the P2Y2 (or P2U) gene (500-bp PCR product) in D (16HBE14o- cells used as a positive control for P2Y2 receptors). NC, "no cDNA," negative PCR control. "No RT" controls were also negative (data not shown). L, 100-bp DNA ladder. These gels are representative of at least 3 PCR amplification with each set of PCR primers.


                              
View this table:
[in this window]
[in a new window]
 
Table 1.   P2X receptor channel mRNA expression in the mIMCD-K2 epithelial cell line as determined by degenerate RT-PCR






View larger version (108K):
[in this window]
[in a new window]
 
Fig. 8.   cDNA sequences confirming the authenticity of mIMCD-K2 P2X and P2Y PCR products. BLAST alignments of P2 purinoceptor mIMCD-K2 PCR products with the closest cloned cDNA sequences are shown. A: P2X3 PCR product alignment with the cloned rat P2X3 receptor (rP2X3R) cDNA sequence. B: P2X4 PCR product alignment with the cloned rat P2X4 receptor (rP2X4R) cDNA sequence. C: P2Y1 PCR product alignment with the cloned mouse P2Y1 receptor (mP2Y1R) cDNA sequence. D: P2Y2 PCR product with the cloned mouse P2Y2 receptor (mP2Y2R) cDNA sequence. Nucleotides in bold show differences in identity; gaps in sequence are shown by the dashed or dotted lines or where indicated.

mIMCD-K2 cells also express P2Y purinoceptor mRNA. Figure 7, C and D, shows representative agarose gels demonstrating positive amplification of a P2Y1 PCR product (750 bp) and P2Y2 PCR product (500 bp), respectively. DNA sequencing of both P2Y2 PCR products confirmed that these PCR products were indeed derived from P2Y2 and P2Y1 mRNA (Fig. 8, C and D). Together, these results suggest that P2Y1 and P2Y2 receptors may regulate transepithelial NaCl transport by mIMCD-K2 monolayers.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The goal of the present study was to determine if nucleotides regulate NaCl transport across mIMCD-K2 cells. Our results demonstrate that nucleotides inhibit INasc through interaction with P2Y purinoceptors expressed in the apical plasma membrane. P2X purinoceptors in the apical membrane also inhibit INasc. In contrast, nucleotides stimulate IClsc across mIMCD-K2 cells through interactions with both P2X and P2Y purinoceptors expressed in the apical plasma membrane. Finally, by RT-PCR, we demonstrated that mIMCD-K2 cells express mRNA for P2X3 and P2X4 purinergic receptor channels and P2Y1 and P2Y2 G protein-coupled purinergic receptors.

Previous research has demonstrated that P2Y2 (or P2U) purinoceptors are expressed in the proximal tubule (8, 26, 46, 49), MDCK cells (17, 39, 40), LLC-PK1 cells (3), A6 cells (36), CCD (32, 41), and IMCD (15, 20, 27). Little is known about P2X purinoceptor expression in renal epithelia. P2X1-like purinoceptors are expressed in LLC-PK1 cells (16). Together, our results provide novel data demonstrating that P2Y1 and P2Y2 receptors and P2X3 and P2X4 receptors expressed in the apical plasma membrane inhibit INasc and stimulate IClsc across mIMCD-K2 cells. Our data are consistent with the hypothesis that nucleotides released from IMCD cells themselves or from other upstream renal epithelial cells activate P2 purinoceptors that regulate Na+ absorption and Cl- secretion. It is important to note that nucleotides are present in the urine and blood in nanomolar to low micromolar (10 µM) concentrations (10, 21, 23, 24), amounts that would stimulate purinoceptors and regulate Na+ and Cl- transport in mIMCD-K2 cells. Recent preliminary results showed that mIMCD-K2 cells release ATP under basal and stimulated conditions into the apical and basolateral solution (35).

The IMCD, and perhaps other nephron segments or cell types in the cortex and/or medulla, may be a source of nucleotides that, once released, can regulate NaCl transport in an autocrine and/or paracrine fashion. Interestingly, our results demonstrate that ATP would affect NaCl transport by the IMCD directly by inhibiting Na+ absorption and stimulating Cl- secretion. Thus ATP would convert NaCl absorption by the IMCD to NaCl secretion (28, 29), thereby enhancing NaCl excretion. It appears, therefore, that ATP and other nucleotides may play an important role in the fine tuning of NaCl transport by the IMCD. The effects of ATP (and, possibly, its metabolites) on glomerular afferent and efferent arterioles may also affect NaCl handling indirectly by affecting glomerular filtration rate (GFR) and renal blood flow. These effects are likely to be complex; for example, ATP is known to stimulate vasoconstriction of afferent, but not efferent, arterioles and to decrease glomerular pressure (10, 23). These effects, in turn, would result in a decrease in GFR and reduced NaCl excretion.

In conclusion, our data demonstrate that nucleotides inhibit Na+ absorption and stimulate Cl- secretion through interactions with P2X purinergic receptors (P2X3, P2X4) and P2Y G protein-coupled receptors (P2Y1, P2Y2) expressed in the apical membrane of mIMCD-K2 cells.


    ACKNOWLEDGEMENTS

We thank Stephanie Kelley and Melissa Levack for excellent technical assistance.


    FOOTNOTES

This work was supported, in part, by the National Institutes of Health (DK-34533 and DK/HL-45881 to B. A. Stanton), the Cystic Fibrosis Foundation (CFF-F992 to D. E. McCoy), and the American Heart Association (New Hampshire Chapter to D. E. McCoy). E. M. Schwiebert is supported by a New Investigator Grant from the American Heart Association (Southern Research Consortium). L. M. Schwiebert is supported by a separate New Investigator Grant from the American Heart Association (Southern Research Consortium).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Address for reprint requests and other correspondence: B. A. Stanton, Dept. of Physiology, Dartmouth Medical School, Hanover, NH 03755 (E-mail: bas{at}dartmouth.edu).

Received 26 March 1998; accepted in final form 4 June 1999.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Abbracchio, M. P., and G. Burnstock. Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol. Ther. 64: 445-475, 1994[Medline].

2.   Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. Basic local alignment search tool (BLAST). J. Mol. Biol. 215: 403-410, 1990[Medline].

3.   Anderson, R. J., R. Breckon, R., and B. S. Dixon. ATP receptor regulation of adenylate cyclase and protein kinase C activity in cultured renal LLC-PK1 cells. J. Clin. Invest. 87: 1732-1738, 1991[Medline].

4.   Barnard, E. A., G. Burnstock, and T. E. Webb. G protein-coupled receptors for ATP and other nucleotides: a new receptor family. Trends Pharmacol. Sci. 15: 67-70, 1994[Medline].

5.   Bean, B. P. Pharmacology and electrophysiology of ATP-activated ion channels. Trends Pharmacol. Sci. 13: 87-90, 1992[Medline].

6.   Boarder, M. R., G. A. Weisman, J. T. Turner, and G. F. Wilkinson. G protein-coupled P2 purinoceptors: from molecular biology to functional responses. Trends Pharmacol. Sci. 16: 133-139, 1995[Medline].

7.   Bogdanov, Y. D., L. Dale, B. F. King, N. Whittock, and G. Burnstock. Early expression of a novel nucleotide receptor in the neural plate of Xenopus embryos. J. Biol. Chem. 272: 12583-12590, 1997[Abstract/Free Full Text].

8.   Bouyer, P., M. Palais, M. Cougnon, P. Hulin, T. Anagnostopoulos, and G. Planelles. Extracellular ATP raises cytosolic calcium and activates basolateral chloride conductance in Necturus proximal tubule. J. Physiol. (Lond.) 510: 535-548, 1998[Abstract/Free Full Text].

9.   Buell, G., G. Collo, and F. Rassendren. P2X receptors: an emerging channel family. Eur. J. Neurosci. 8: 2221-2228, 1996[Medline].

10.   Chan, C. M., R. J. Unwin, and G. Burnstock. Potential functional roles of extracellular ATP in kidney and urinary tract. Exp. Nephrol. 6: 200-207, 1998[Medline].

11.   Collo, G., R. A. North, E. Kawashima, E. Merlo-Rich, S. Neidhart, A. Suprenant, and G. Buell. Cloning of P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J. Neurosci. 16: 2495-2507, 1996[Abstract].

12.   Communi, D., C. Govaerts, M. Parmentier, M., and J.-M. Boeynaems. Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. J. Biol. Chem. 272: 31969-31973, 1997[Abstract/Free Full Text].

13.   Dalziel, H. H., and D. P. Westfall. Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization. Pharmacol. Rev. 46: 449-466, 1994[Medline].

14.   Dubyak, G., and C. El-Moatassim. Signal transduction via P2 purinoceptors for extracellular ATP and other nucleotides. Am. J. Physiol. 265 (Cell Physiol. 34): C577-C606, 1993[Abstract/Free Full Text].

15.   Ecelbarger, C. A., Y. Maeda, C. C. Gibson, and M. A. Knepper. Extracellular ATP increases intracellular calcium in rat terminal collecting duct via a nucleotide receptor. Am. J. Physiol. 267 (Renal Fluid Electrolyte Physiol. 36): F998-F1006, 1994[Abstract/Free Full Text].

16.   Filipovic, D. M., O. A. Adebanjo, M. Zaidi, and W. B. Reeves. Functional and molecular evidence for P2X receptors in LLC-PK1 cells. Am. J. Physiol. 274 (Renal Physiol. 43): F1070-F1077, 1998[Abstract/Free Full Text].

17.   Firestein, B. L., M. Xing, R. J. Hughes, C. U. Corvera, and P. A. Insel. Heterogeneity of P2U and P2Y purinoceptor regulation of phospholipases in MDCK cells. Am. J. Physiol. 271 (Renal Fluid Electrolyte Physiol. 40): F610-F618, 1996[Abstract/Free Full Text].

18.   Fredholm, B. B., M. P. Abbracchio, G. Burnstock, J. W. Daly, T. K. Harden, K. J. Jacobson, P. Leff, and M. Williams. Nomenclature and classification of purinoceptors: a report from the IUPHAR subcommittee. Pharmacol. Rev. 46: 143-156, 1994[Medline].

19.   Friedrich, F., H. Weiss, M. Paulmichl, E. Woll, S. Waldegger, and F. Lang. Further analysis of ATP-mediated activation of K+ channels in renal epitheloid Madin Darby canine kidney (MDCK) cells. Eur. J. Physiol. 418: 551-555, 1991[Medline].

20.   Ginns, S. N., S. Nielsen, M. A. Knepper, and B. K. Kishore. Immunolocalization of extracellular nucleotide receptor (P2U) in renal inner medulla (Abstract). FASEB J. 11: A9, 1997.

21.   Gordon, J. L. Extracellular ATP: effects, sources and fate. Biochem. J. 233: 309-319, 1986[Medline].

22.   Harden, T. K., J. L. Boyer, and R. A. Nicholas. P2 purinoceptors: subtype-associated signaling responses and structure. Annu. Rev. Pharmacol. Toxicol. 35: 541-579, 1995[Medline].

23.   Inscho, E. W., K. D. Mitchell, and L. G. Navar. Extracellular ATP in the regulation of renal microvascular function. FASEB J. 8: 319-328, 1994[Abstract/Free Full Text].

24.   Ishikawa, S., M. Higashiyama, I. Kusaka, T. Saito, S. Nagasaka, and S. Fukuda. Extracellular ATP promotes cellular growth of renal inner medullary collecting duct cells mediated by P2U receptors. Nephron 76: 208-214, 1997[Medline].

25.   Iwase, N., T. Sasaki, S. Shimura, M. Yamamoto, S. Suzuki, and K. Sharito. ATP-induced Cl- secretion with suppressed Na+ absorption in rabbit tracheal epithelium. Respir. Physiol. 107: 173-180, 1997[Medline].

26.   Jin, W., and U. Hopfer. Purinergic-mediated inhibition of Na+-K+-ATPase in proximal tubule cells: elevated cytosolic calcium is not required. Am. J. Physiol. 272 (Cell Physiol. 41): C1169-C1177, 1997[Abstract/Free Full Text].

27.   Kishore, B. K., C. L. Chou, and M. A. Knepper. Extracellular nucleotide receptor inhibits AVP-stimulated water permeability in inner medullary collecting duct. Am. J. Physiol. 269 (Renal Fluid Electrolyte Physiol. 38): F863-F869, 1995[Abstract/Free Full Text].

28.   Kizer, N. L., B. Lewis, and B. A. Stanton. Electrogenic sodium absorption and chloride secretion by an inner medullary collecting duct cell line (mIMCD-K2). Am. J. Physiol. 268 (Renal Fluid Electrolyte Physiol. 37): F347-F355, 1995[Abstract/Free Full Text].

29.   Kizer, N. L., D. Vandorpe, B. Lewis, B. Bunting, J. Russell, and B. A. Stanton. Vasopressin and cAMP stimulate electrogenic chloride secretion in an IMCD cell line. Am. J. Physiol. 268 (Renal Fluid Electrolyte Physiol. 37): F854-F861, 1995[Abstract/Free Full Text].

30.   Knowles, M. R., L. L. Clarke, and R. C. Boucher. Activation by extracellular nucleotides of chloride secretion in airway epithelia of patients with cystic fibrosis. N. Engl. J. Med. 325: 533-538, 1991[Abstract].

31.   Knowles, M. R., L. L. Clarke, and R. C. Boucher. Extracellular ATP and UTP induce chloride secretion in nasal epithelia of cystic fibrosis patients and normal subjects in vivo. Chest 101: 60-63, 1992.

32.   Koster, H. P., A. Hartog, C. H. van Os, and R. J. M. Bindels. Inhibition of Na+ and Ca2+ reabsorption by P2U purinoceptors requires PKC but not calcium signaling. Am. J. Physiol. 270 (Renal Fluid Electrolyte Physiol. 39): F53-F60, 1996[Abstract/Free Full Text].

33.   Le, K. T., K. Babinski, and P. Seguela. Central P2X4 and P2X6 channel subunits coassemble into a novel heteromeric ATP receptor. J. Neurosci. 18: 7152-7159, 1998[Abstract].

34.   Lewis, C., S. Neidhart, C. Holy, R. A. North, G. Buell, and A. Surprenant. Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature 377: 432-435, 1995[Medline].

35.   McCoy, D. E., B. A. Stanton, W. B. Guggino, and E. M. Schwiebert. ATP release and nucleotide regulation of Na+ and Cl- transport in mouse mIMCD-K2 cells (Abstract). J. Am. Soc. Nephrol. 7: 1285, 1996.

36.   Middleton, J. P., A. W. Mangel, S. Basavappa, S., and J. G. Fitz. Nucleotide receptors regulate membrane ion transport in renal epithelial cells. Am. J. Physiol. 264 (Renal Fluid Electrolyte Physiol. 33): F867-F873, 1993[Abstract/Free Full Text].

37.   Moyer, B. D., D. E. McCoy, B. Lee, N. Kizer, and B. A. Stanton. Adenosine inhibits arginine vasopressin-stimulated chloride secretion in a mouse IMCD cell line (mIMCD-K2). Am. J. Physiol. 269 (Renal Fluid Electrolyte Physiol. 38): F884-F891, 1995[Abstract/Free Full Text].

38.   Nicholas, R. A., W. C. Watt, E. R. Lazarowski, Q. Li, and T. K. Harden. Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: Identification of a UDP-selective, and an ATP- and UTP-specific receptor. Mol. Pharmacol. 50: 224-229, 1996[Abstract].

39.   Post, S. R., J. P. Jacobson, and P. A. Insel. P2 purinergic receptor agonists enhance cAMP production in Madin-Darby canine kidney epithelial cells via an autocrine/paracrine mechanism. J. Biol. Chem. 271: 2029-2032, 1996[Abstract/Free Full Text].

40.   Post, S. R., L. C. Rump, A. Zambon, R. J. Hughes, M. D. Buda, J. P. Jacobson, C. C. Kao, and P. A. Insel. ATP activates cAMP production via multiple purinergic receptors in MDCK-D1 epithelial cells. Blockade of an autocrine/paracrine pathway to define receptor preference of an agonist. J. Biol. Chem. 273: 23093-23097, 1998[Abstract/Free Full Text].

41.   Rouse, D., M. Leite, and W. N. Suki. ATP inhibits the hydrosmotic effect of AVP in rabbit CCT: evidence for a nucleotide P2U receptor. Am. J. Physiol. 267 (Renal Fluid Electrolyte Physiol. 36): F289-F295, 1994[Abstract/Free Full Text].

42.   Schwiebert, E. M., M. E. Egan, T.-H. Hwang, S. B. Fulmer, S. S. Allen, G. R. Cutting, and W. B. Guggino. CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP. Cell 81: 1063-1073, 1995[Medline].

43.   Seguela, P., A. Haghighi, J. J. Soghomonian, and E. Cooper. A novel neuronal P2X ATP receptor ion channel with widespread distribution in the brain. J. Neurosci. 16: 448-455, 1996[Abstract].

44.   Simmons, N. L. Stimulation of Cl- secretion by exogenous ATP in cultured MDCK epithelial monolayers. Biochim. Biophys. Acta 646: 231-242, 1981[Medline].

45.   Suprenant, A., F. Rassendren, E. Kawashima, R. A. North, and G. Buell. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272: 735-738, 1996[Abstract].

46.   Takeda, M., M. Kobayashi, and H. Endou. Establishment of a mouse clonal early proximal tubule cell line and outer medullary collecting duct cells expressing P2 purinoceptors. Biochem. Mol. Biol. Int. 44: 657-664, 1998[Medline].

47.   Valera, S., N. Hussy, R. J. Evans, N. Adami, R. A. North, A. Surprenant, and G. Buell. A new class of ligand-gated ion channel defined by P2X receptor for extracellular ATP. Nature 371: 516-519, 1994[Medline].

48.   Vandorpe, D., N. Kizer, F. Ciampolillo, V. A. Memoli, W. B. Guggino, and B. A. Stanton. CFTR mediate electrogenic chloride secretion in mouse inner medullary collecting duct (mIMCD-K2) cells. Am. J. Physiol. 269 (Cell Physiol. 38): C683-C689, 1995[Abstract].

49.   Yamada, H., G. Seki, S. Taniguchi, S. Uwatoko, K. Suzuki, and K. Kurokawa. Mechanism of [Ca2+]i increase by extracellular ATP in isolated rabbit renal proximal tubules. Am. J. Physiol. 270 (Cell Physiol. 39): C1096-C1104, 1996[Abstract/Free Full Text].


Am J Physiol Renal Physiol 277(4):F552-F559
0002-9513/99 $5.00 Copyright © 1999 the American Physiological Society